Optimizing Enteral Nutrition Regimen for Critically Ill Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHamad Medical Corporation

About this trial

Clinical Trial The goal of this clinical trial is to learn whether different enteral feeding cycles (18-hour, 20-hour, or standard 24-hour continuous feeding) improve outcomes for critically ill ICU patients who need tube feeding. It will also look at tolerance, nutrition delivery, and safety.

The main questions it aims to answer are:

Do shorter feeding cycles (with fasting windows) reduce ICU length of stay?

Do they lower the risk of infections like ventilator-associated pneumonia?

How do they affect calorie delivery, blood sugar control, and gastrointestinal tolerance?

Researchers will compare:

Continuous 24-hour feeding (standard care)

20-hour feeding with a 4-hour fasting window

18-hour feeding with a 6-hour fasting window

Participants will:

Be critically ill adults in the ICU who require at least 7 days of enteral feeding

Be randomized to one of the three feeding schedules

Receive daily monitoring of calories, protein, blood sugar, and GI tolerance

Have outcomes measured, including ICU length of stay, infections, metabolic control, and feeding tolerance

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged ≥ 18 years.

Patients expected to require enteral nutrition (EN) for ≥ 7 days.

Critically ill, mechanically ventilated patients in the ICU.

New patients initiating EN in the critical care unit.

Disqualifiers

Active GI bleeding.

Progressive GI disease.

Recent GI tract resection.

Indication for a special diet formula.

Trial design

Design model

Parallel

Treatments tested in this trial

  • 20-Hour Cycled Enteral Nutrition with a 4-Hour Fasting Window

    Behavioral

    20-Hour Cycled Enteral Nutrition with a 4-Hour Fasting Window (Intervention 1) Objective: To evaluate the physiological benefits of a structured daily fasting period while maintaining a conservative approach to caloric delivery.

  • 18-Hour Cycled Enteral Nutrition with a 6-Hour Fasting Window

    Behavioral

    Feeding Schedule involves enteral nutrition over an 18-hour period while incorporating a 6-hour fasting window in each 24-hour cycle. This structure is designed to test a more intense intermittent fasting regimen, aiming to enhance physiological benefits by better aligning with circadian rhythms. The expectations include improved metabolic control, enhanced gastrointestinal motility, and reduced infection rates, with careful monitoring for reduced caloric intake risk. Consequently, the feeding rate is increased to meet daily caloric goals within the 18-hour timeframe, resulting in the most intensive feeding schedule among the three examined arms.

Treatment groups

150 Participants
are divided into 3 treatment groups
Group A: 24-hour continuous feeding (control)No intervention 0 interventions
Group B: 20-hour cycled feeding (intervention)Active comparator 1 intervention
Group C: 18-hour cycled feeding (intervention)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

ICU Length of Stay (LOS)

The total number of days a patient spends in the intensive care unit, calculated from the date of ICU admission to the date of discharge or transfer out of the ICU.

Time frame
From the date of randomization until the date of ICU discharge or transfer, assessed up to 90 days (or until hospital discharge if it occurs earlier).

Secondary outcomes

1

Nosocomial Infection/Pneumonia Incidence

Infections acquired after 48 hours of hospital admission, specifically including Ventilator-Associated Pneumonia (VAP). Diagnosed based on CDC criteria (clinical signs, laboratory findings, and imaging).

Time frame
Assessed daily from Day 3 to Day 7.
2

Nutritional Adequacy

The percentage of the prescribed daily caloric goal that is actually delivered to the patient.

Time frame
Calculated daily from Day 1 to Day 7
3

Gastrointestinal Complications

Adverse events related to feeding intolerance.

Time frame
Monitored daily from Day 1 to Day 7
4

Gastric Emptying Index

A measure of gastrointestinal motility, indicated by delayed gastric emptying. Aspirate gastric contents via a nasogastric (NG) or orogastric (OG) tube at regular intervals (every 4 hours). gastric residual volume ≤ 500 mL, persistently high GRV (\>500 mL) indicates delayed emptying.

Time frame
Measured every 4 hours, daily from Day 1 to Day 7.

Other outcomes

1

Inflammatory Marker

Level of systemic inflammation by Inflammatory Markers (e.g., CRP)

Time frame
Measured daily from Day 1 to Day 7.The baseline value is recorded on Day 0.
2

Patient Tolerance

The ability to receive enteral nutrition without significant adverse effects.

Time frame
Measured daily from Day 1 to Day 7

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: